₹103.42
−2.56%NSE close, 16 Nov 2026
+28.86%
Gaudium IVF and Women Health is a small cap company, listed on NSE under the symbol GAUDIUMIVF. At ₹103.42 a share, the market values the whole company at ₹753 crore.
In FY26, it reported sales of ₹104 crore and a net profit of ₹24 crore, an operating margin of 36.1%.
The market values the company at 32.5 times its profit over the last twelve months and 4.61 times its book value; its return on equity is 14.2% and it has almost no borrowings.
Promoters hold 71.29% of the shares. Foreign institutions hold 1.19%, and domestic institutions, mutual funds among them, 2.22%.
₹ crore. Consolidated figures.
Notice of Postal Ballot dated November 16, 2026.
Rectification of inadvertent typographical error in the Unaudited Financial Results submitted as part of the Outcome of the Board Meeting held on November 12, 2026
Monitoring Agency Report for quarter ended September 30, 2026.
Revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015.
| 26.7% |
| 40.1% |
| 12.5% |
| 36.0% |
| Other income | 0.1 | 0.2 | 1.1 | 1.1 |
|---|
| Interest | 1.2 | 1.3 | 0.4 | 0.5 |
|---|
| Depreciation | 0.5 | 0.6 | 0.7 | 1.4 |
|---|
| Profit before tax | 5.0 | 10.4 | 2.5 | 12.6 |
|---|
| Tax | 1.3 | 2.1 | 0.7 | 3.2 |
|---|
| Net profit | 3.6 | 8.4 | 1.8 | 9.4 |
|---|
| EPS (₹) | 0.59 | 1.34 | 0.25 | 1.29 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 104 |
| Expenses | 66.7 |
| Operating profit | 37.7 |
| Operating margin | 36.1% |
| Other income | 0.5 |
| Interest | 3.5 |
| Depreciation | 2.6 |
| Profit before tax | 32.2 |
| Tax | 7.7 |
| Net profit | 24.5 |
| EPS (₹) | 3.92 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 7.3 | 19.8 |
| From investing | −87.7 | 15.1 |
| From financing | 82.0 | −23.1 |
| Spent on fixed assets | −2.1 | −2.3 |
| Free cash flow | 5.1 | 17.4 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 23.4% |
| Operating margin | 36.1% |
| Return on equity | 16.1% |
| Return on capital employed | 20.4% |
| Return on assets | 12.7% |
| Debt to equity | 0.15 |
| Interest coverage | 10.20 |
| Debt to assets | 0.12 |
| Current ratio | 1.90 |
| Quick ratio | 1.81 |
| Cash ratio | 0.23 |
| Asset turnover | 0.54 |
| Fixed asset turnover | 13.99 |
| Inventory turnover | 9.50 |
| Receivables turnover | 2.00 |
| Gross margin | 67.8% |
| Cash from operations to profit | 30.0% |
| Effective tax rate | 23.9% |
Press Release on Unaudited Financial Results for the quarter and half year ended September 30, 2026
Appointment of Mr. Ravish Manchanda, National Head Operations Expansion & Strategy, as Senior Management Personnel of the Company.
The Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2026
Schedule of meet
The Voting Results and Consolidated Scrutinizers Report of the 11th Annual General Meeting of the Company.
Proceedings of 11th Annual General Meeting of the Company held on Monday, September 28, 2026.
Commencement of commercial operations at Company's new IVF Centre/Hub at Gurgaon, Haryana
Letter Shareholders providing the weblink and navigation path for accessing the Annual Report for the Financial Year 2025-26 pursuant to Regulation 36(1)(b) of Listing Regulations.
Notice of Annual General Meeting to be held on September 28, 2026